HEALTH UTILITIES ASSOCIATED WITH HYPOGLYCEMIC EVENTS IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS RECEIVING BASAL-BOLUS INSULIN THERAPY

被引：1
|
作者：
Ionova, T. [1 ]
Nikitina, T. [1 ]
Kurbatova, K. [2 ]
机构：
[1] Natl Pirogov Med Surg Ctr, Moscow, Russia
[2] Multinatl Ctr Qual Life Res, St Petersburg, Russia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2112
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB73
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [41] Efficacy of metformin alone or in combination with insulin in pediatric patients with type 2 diabetes mellitus (T2DM)
    Weinzimer, SA
    McKnight, WJ
    Murphy, K
    Jawad, AF
    Celona-Jacobs, N
    Haque, A
    Katz, LEL
    DIABETES, 2001, 50 : A68 - A68
  • [42] Comparison of canagliflozin and liraglutide as a replacement for bolus insulin in type 2 diabetes patients well-controlled by basal-bolus insulin
    Kumashiro, N.
    Ando, Y.
    Shigiyama, F.
    Igarashi, H.
    Yoshikawa, F.
    Uchino, H.
    Yoshino, H.
    Miyagi, M.
    Ikehara, K.
    Hirose, T.
    DIABETOLOGIA, 2018, 61 : S126 - S126
  • [43] THE COSTS OF INTENSIFICATION FROM BASAL INSULIN TO BASAL-BOLUS IN TYPE 2 DIABETES: A SURVEY OF PHYSICIANS
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [44] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [45] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [46] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [47] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [48] LITERATURE REVIEW OF ECONOMIC AND CLINICAL OUTCOMES ASSOCIATED WITH MULTIPLE DAILY INSULIN INJECTION (MDI) THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Mathur, I
    Trenery, A.
    Simon, A.
    Gala, S.
    Ermakova, A.
    Weiss, M.
    Taylor, S.
    VALUE IN HEALTH, 2019, 22 : S149 - S149
  • [49] ACHIEVEMENT OF GLYCAEMIC TARGETS WITH CANAGLIFLOZIN IN TRIPLE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Diels, J.
    Schubert, A.
    Hamilton, G.
    Canovatchel, W.
    VALUE IN HEALTH, 2015, 18 (07) : A598 - A598
  • [50] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    DIABETES, 2006, 55 : A111 - A111
12345